Prestige Brands Holdings Inc. Second Quarter Earnings Sneak Peek

Prestige Brands Holdings, Inc. (NYSE:PBH) will unveil its latest earnings on Thursday, November 10, 2011. Prestige Brands sells well-recognized, brand name over-the-counter healthcare, household cleaning, and personal care products in a global marketplace.

Prestige Brands Holdings, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 26 cents per share, a rise of 13% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 27 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 26 cents during the last month. For the year, analysts are projecting profit of 95 cents per share, a rise of 20.3% from last year.

Past Earnings Performance: The company has fallen in line with estimates the last two quarters. In the first quarter, it reported net income of 23 cents per share and two quarters ago booked profit of 18 cents.

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.

Wall St. Revenue Expectations: On average, analysts predict $104.7 million in revenue this quarter, a rise of 33.7% from the year ago quarter. Analysts are forecasting total revenue of $403.9 million for the year, a rise of 20% from last year’s revenue of $336.5 million.

Analyst Ratings: Analysts seem relatively indifferent about Prestige Brands Holdings with three of five analysts surveyed maintaining a hold rating.

A Look Back: In the first quarter, profit rose 53.8% to $14.8 million (29 cents a share) from $9.6 million (19 cents a share) the year earlier, meeting analyst expectations. Revenue rose 29.8% to $95.3 million from $73.4 million.

Key Stats:

Revenue has gone up for three straight quarters. It rose 35% in the fourth quarter of the last fiscal year from the year earlier and 20.1% in the third quarter of the last fiscal year.

Competitors to Watch: The Procter & Gamble Co. (NYSE:PG), Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK), Perrigo Company (NASDAQ:PRGO), Watson Pharmaceuticals, Inc. (NYSE:WPI), Taro Pharmaceutical Industries Ltd. (TAROF), Hi-Tech Pharmacal Co. (NASDAQ:HITK), Allergan, Inc. (NYSE:AGN), GlaxoSmithKline plc (NYSE:GSK), and Akorn, Inc. (NASDAQ:AKRX).

Stock Price Performance: During October 7, 2011 to November 4, 2011, the stock price had risen $1.37 (15.1%) from $9.07 to $10.44. The stock price saw one of its best stretches over the last year between June 24, 2011 and July 1, 2011 when shares rose for six-straight days, rising 9% (+$1.08) over that span. It saw one of its worst periods between July 22, 2011 and August 8, 2011 when shares fell for 12-straight days, falling 29.7% (-$3.97) over that span. Shares are down $1.51 (-12.6%) year to date.

(Source: Xignite Financials)

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.